This is a preview of subscription content, log in via an institution to check access.
Reference
Lairson DR, et al. Cost-Utility Analysis of Platinum-Based Chemotherapy versus Taxane and Other Regimens for Ovarian Cancer. Value in Health 17: 34-42, No. 1, Jan 2014
Additional information
* incremental cost-effectiveness ratio
Rights and permissions
About this article
Cite this article
Platinum-based chemo cost effective in the real world. PharmacoEcon Outcomes News 695, 8 (2014). https://doi.org/10.1007/s40274-014-1010-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1010-0